Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Opko
MedTech
Sema4 signals $623M bid for genetic testing provider GeneDx
Fresh off a SPAC deal that brought in $500 million in cash proceeds, Sema4 is putting those earnings to good use.
Andrea Park
Jan 18, 2022 9:51am
Pfizer stumbles close to finish line in growth hormone race
Sep 27, 2021 7:05am
Pfizer, Opko's growth hormone en route to October FDA decision
Jan 4, 2021 9:15am
Pfizer presents growth hormone data ahead of FDA filing
Oct 8, 2020 8:35am
Vifor flies solo, plans spending spree as sister unit files IPO
Apr 7, 2017 2:38am
Pfizer, Opko end 2016 downbeat as hGH-CTP fails phase 3 trial
Dec 30, 2016 9:40am